These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 713816)
21. [Study of a programmed release preparation of betahistine mesylate in the treatment of Ménière's disease (author's transl)]. Pialoux P Ann Otolaryngol Chir Cervicofac; 1981; 98(9):483-6. PubMed ID: 7041769 [TBL] [Abstract][Full Text] [Related]
22. [Picrotoxin in the treatment of Menière's disease]. Weikert S; Rotter A; Scherer H; Hölzl M Laryngorhinootologie; 2008 Dec; 87(12):862-6. PubMed ID: 18720328 [TBL] [Abstract][Full Text] [Related]
24. An agent for the amelioration of vertigo in Ménière's syndrome. Betahistine hydrochloride (Serc). JAMA; 1968 Mar; 203(13):1122. PubMed ID: 4966735 [No Abstract] [Full Text] [Related]
25. The effect of betahistine hydrochloride in Méniére's disease. Wilmot TJ Acta Otolaryngol Suppl; 1972; 305():18-21. PubMed ID: 4353748 [No Abstract] [Full Text] [Related]
26. [Therapy of peripheral vestibular vertigo with betahistine dimesilate (Aequamen)]. Reker U MMW Munch Med Wochenschr; 1983 Oct; 125(41):915-8. PubMed ID: 6417495 [No Abstract] [Full Text] [Related]
27. Vasodilators in Menière's syndrome. Tuke JU Br Med J; 1971 Nov; 4(5784):431. PubMed ID: 5001364 [No Abstract] [Full Text] [Related]
28. The clinical drug trial in Menière's disease with emphasis on the effect of betahistine SR. Schmidt JT; Huizing EH Acta Otolaryngol Suppl; 1992; 497():1-189. PubMed ID: 1496890 [No Abstract] [Full Text] [Related]
29. Méniére's disease: subjective and objective evaluation of medical treatment with betahistine HCl. Bertrand RA Acta Otolaryngol Suppl; 1972; 305():48-69. PubMed ID: 4353750 [No Abstract] [Full Text] [Related]
30. [Drug information. Therapeutic main group: agents for the treatment of dizziness--betahistine]. Lumholtz IB Sygeplejersken; 1979 Mar; 79(12):28. PubMed ID: 254983 [No Abstract] [Full Text] [Related]
31. [Therapeutic results of betahistine on Meniere's disease. Multi-variable analysis of the results of the double blind test and Fisher's evaluation method]. Okamoto K; Hazeyama F; Taira T; Yoshida A; Onoda T Iryo; 1968 May; 22(5):650-66. PubMed ID: 4972506 [No Abstract] [Full Text] [Related]
32. An objective study of the effect of betahistine hydrochloride on hearing and vestibular function tests in patients with Ménière's disease. Wilmot TJ J Laryngol Otol; 1971 Apr; 85(4):369-73. PubMed ID: 4995451 [No Abstract] [Full Text] [Related]
33. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study]. Kluyskens P; Lambert P; D'Hooge D Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994 [TBL] [Abstract][Full Text] [Related]
34. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease. Fraysse B; Bebear JP; Dubreuil C; Berges C; Dauman R Acta Otolaryngol Suppl; 1991; 490():1-10. PubMed ID: 1763646 [TBL] [Abstract][Full Text] [Related]
35. Betahistine hydrochloride (serc) for Meniere's syndrome. Med Lett Drugs Ther; 1967 Apr; 9(8):29-30. PubMed ID: 6040170 [No Abstract] [Full Text] [Related]
36. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease. Ganança MM; Caovilla HH; Ganança FF Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332 [TBL] [Abstract][Full Text] [Related]